EGFR Positive Non-small Cell Lung Cancer

Oncology

Prevalence

30.0 / 100K

1 drug in development·1 company·1 clinical trial

Drug Pipeline by Phase

Frequently asked questions

How many drugs are in development for EGFR Positive Non-small Cell Lung Cancer?

BioSniper tracks 1 drug in development for EGFR Positive Non-small Cell Lung Cancer across 1 company.

How many clinical trials target EGFR Positive Non-small Cell Lung Cancer?

There are 1 clinical trial targeting EGFR Positive Non-small Cell Lung Cancer tracked by BioSniper.

What is the prevalence of EGFR Positive Non-small Cell Lung Cancer?

The estimated prevalence of EGFR Positive Non-small Cell Lung Cancer is approximately 30.0 per 100,000 population.

Deep-dive into EGFR Positive Non-small Cell Lung Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    EGFR Positive Non-small Cell Lung Cancer — Drugs in Development & Clinical Trials | BioSniper